Form 4 for BBNX Beta Bionics, Inc.
Accepted 2026-06-05 18:05:07 ET · period of report 2026-06-04 · accession 0002048497-26-000008 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-06-05 18:05 | 2026-06-04 | BBNX | Hopman Mark | Chief Commercial Off | S - Sale | $12.31 | -275 | 130.6K | -0.2% | -$3,385 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-04 | S | D | 275 | $12.31 | 130,612 | D | — | — | (F1) Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on May 13, 2025. |